Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| GLOBAL GEOPH | GGS | 7.79% |
| STAAR SURGIC | STAA | 6.23% |
| KAPSTONE PAP | KS | 6.14% |
| HORNBECK OFF | HOS | 5.99% |
| ANIKA THERAP | ANIK | 5.55% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Janus Capital Group Inc. (JNS - Analyst Report) reported third quarter 2012 earnings per share attributable to common shareholders of 15 cents, in line with the Zacks Consensus Estimate as well as the year-ago quarter’s earnings. Including an intangible asset impairment charge of 1 cent per share related to the redemption of a sub-advised account, earnings stood at 14 cents.
Lower top-line growth and net outflows were the negatives for the quarter. However, decline in operating expenses reflect better expense management.
Net income attributable to common shareholders stood at $25.1 million compared with $27.4 million in the prior-year quarter.
Performance in Detail
Total revenue plunged 11.8% year over year to $209 million in the quarter. The year-over-year decline reflects negative performance fees driven by underperformance of certain mutual funds along with lower investment management fees. However, the revenue figure surpassed the Zacks Consensus Estimate of $206.0 million.
Total operating expenses decreased 1.0% year over year to $161.1 million. The decline was mainly driven by lower distribution expenses and reduced employee compensation and benefits expenses. Operating margin was 22.9% compared with 31.3% in the year-ago quarter.
Asset Position
As of September 30, 2012, Janus Capital reported assets under management (AUM) of $158.2 billion, up from $141.0 billion as of September 30, 2011. Average AUM decreased slightly on a year-over-year basis to $155.5 billion.
The increase in overall assets mainly reflects net market appreciation of $7.8 billion, partially offset by long-term net outflows of $2.0 billion. Long-term net inflows at fixed income and mathematical equity totaled $1.0 billion and $0.3 billion, respectively, partially offset by fundamental equity long-term net outflows of $3.3 billion.
Balance Sheet
As of September 30, 2012, Janus Capital had stockholders’ equity of $1.4 billion, cash and investments of $683.6 million and outstanding debt of $542.8 million.
Cash flows from operations were $75.3 million compared with $47.8 million in the prior-year quarter.
Capital Deployment Activity
During the third quarter of 2012, Janus Capital repurchased 773,300 shares of its common stock at an average price of $8.12 per share and at a total cost of $6.3 million.
Recently, Janus Capital’s Board of Directors declared a regular quarterly cash dividend of 6 cents per share. The dividend will be paid on November 19, 2012 to shareholders of record as of November 5, 2012.
Our Viewpoint
Janus Capital faces increasing competition from its peers, Fortress Investment Group LLC (FIG - Snapshot Report) and Federated Investors Inc. (FII - Analyst Report). The company has the best-in-class investment boutique with the potential for AUM and revenue along with competitive leverage growth. However, weakness in flows remains a matter of concern.
Though the fixed income segment and global operations are showing signs of improvement, the company’s equity-heavy portfolio makes it vulnerable to the volatilities of the equity market. Further, a low interest rate environment will likely affect the money market business. Nevertheless, given its healthy balance sheet, we believe Janus Capital has the potential to perform well in the long run.
Shares of Janus Capital currently retain a Zacks #2 Rank, which translates into a short-term Buy rating. However, considering the fundamentals, we maintain a ‘Neutral’ recommendation on the stock.
Get the full Analyst Report on JNS - FREE
Get the full Analyst Report on FII - FREE
Get the full Snapshot Report on FIG - FREE